Cotiviti (COTV) Given Daily News Impact Score of 0.20

News articles about Cotiviti (NYSE:COTV) have been trending somewhat positive on Sunday, according to Accern Sentiment Analysis. The research firm rates the sentiment of news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cotiviti earned a media sentiment score of 0.20 on Accern’s scale. Accern also assigned media headlines about the business services provider an impact score of 45.8517890527424 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Shares of NYSE:COTV opened at $34.65 on Friday. The firm has a market cap of $3,214.43, a price-to-earnings ratio of 24.40, a price-to-earnings-growth ratio of 1.60 and a beta of 0.82. Cotiviti has a 1-year low of $30.84 and a 1-year high of $45.97. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.73 and a current ratio of 1.73.

How to Become a New Pot Stock Millionaire

Cotiviti (NYSE:COTV) last issued its earnings results on Wednesday, February 21st. The business services provider reported $0.47 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.43 by $0.04. The company had revenue of $176.70 million for the quarter, compared to analysts’ expectations of $179.43 million. Cotiviti had a net margin of 20.36% and a return on equity of 13.29%. The firm’s revenue was up 5.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.39 earnings per share. equities research analysts anticipate that Cotiviti will post 1.67 EPS for the current year.

Several analysts recently issued reports on COTV shares. Zacks Investment Research cut shares of Cotiviti from a “hold” rating to a “strong sell” rating in a report on Tuesday, January 2nd. Citigroup started coverage on shares of Cotiviti in a report on Thursday, January 4th. They issued a “buy” rating on the stock. Finally, First Analysis cut shares of Cotiviti from an “overweight” rating to an “equal weight” rating and cut their price target for the company from $48.00 to $40.00 in a report on Friday, February 23rd. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company’s stock. Cotiviti presently has an average rating of “Buy” and an average price target of $40.88.

In other news, CEO J Douglas Williams sold 30,000 shares of the company’s stock in a transaction dated Wednesday, January 24th. The shares were sold at an average price of $34.80, for a total transaction of $1,044,000.00. Following the completion of the transaction, the chief executive officer now owns 2,766,660 shares in the company, valued at $96,279,768. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO David Beaulieu sold 5,000 shares of the company’s stock in a transaction dated Wednesday, April 18th. The stock was sold at an average price of $35.00, for a total transaction of $175,000.00. Following the transaction, the chief operating officer now owns 44,425 shares of the company’s stock, valued at approximately $1,554,875. The disclosure for this sale can be found here. Insiders have sold 175,000 shares of company stock worth $6,055,250 over the last three months. 15.80% of the stock is owned by corporate insiders.

WARNING: This report was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The original version of this report can be viewed at

About Cotiviti

Cotiviti Holdings, Inc, through its subsidiaries, provides analytics-driven payment accuracy and spend management solutions primarily for the healthcare sector in the United States, Canada, the United Kingdom, and India. It operates through two segments, Healthcare, and Global Retail and Other. The company offers prospective claims accuracy solutions that enable healthcare clients identify and address claim discrepancies immediately following claim adjudication and before a claim is paid to a healthcare provider; and retrospective claims accuracy solutions that enable health insurers identify and resolve payment inaccuracies after a claim has been paid to a healthcare provider.

Insider Buying and Selling by Quarter for Cotiviti (NYSE:COTV)

Receive News & Ratings for Cotiviti Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cotiviti and related companies with's FREE daily email newsletter.

Leave a Reply